J. E. de Leeuw van Weenen

Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men

Sólrún Vidarsdóttir, J. E. de Leeuw van Weenen, Marijke Frölich et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 88 citations · Full text

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

J. E. de Leeuw van Weenen, Edwin T. Parlevliet, Pierre Maechler et al. · Biochemical Pharmacology · 2010 · 78 citations

Molecular Pharmacology, Medicine, Insulin Management +9

GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet

Edwin T. Parlevliet, J. E. de Leeuw van Weenen, Johannes A. Romijn et al. · American Journal of Physiology-Endocrinology and Metabolism · 2010 · 77 citations

High-fat Diet, Central Glp-1 Receptors, Insulin Signaling +16

Pharmacological Modulation of Dopamine Receptor D2-Mediated Transmission Alters the Metabolic Phenotype of Diet Induced Obese and Diet Resistant C57Bl6 Mice

J. E. de Leeuw van Weenen, Edwin T. Parlevliet, Janny P. Schröder-van der Elst et al. · Experimental Diabetes Research · 2011 · 21 citations · Full text

Metabolic Disorder, High Fat Feeding, Obesity +19

Four weeks high fat feeding induces insulin resistance without affecting dopamine release or gene expression patterns in the hypothalamus of C57Bl6 mice

J. E. de Leeuw van Weenen, Lu Hu, K. Jansen-Van Zelm et al. · Brain Research · 2008 · 17 citations

Obesity, Metabolic Syndrome, Energy Homeostasis +11